ESC Professional Premium Access

What’s new on lipids and diabetes in acute coronary syndrome

Event: ESC Congress 2022
Topic: Pharmacotherapy
Session type: Abstract Sessions
Date: 28 August 2022
Time: 15:30 - 16:30

Congress Session

6 presentations in this session

Lipoprotein(a) and the effect of alirocumab on coronary and non-coronary revascularization following acute coronary syndrome

Speaker: Professor P. Steg (Paris, FR)
Thumbnail

Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and interaction with the vascular endothelium: the impact of PCSK9 inhibition with evolocumab in acute coronary syndrome

Speaker: Doctor E. Ziogos (Baltimore, US)
Thumbnail

Quality matters: low-density lipoprotein electronegativity but not quantity determines mortality risk in acute coronary syndromes

Speaker: Doctor S. Kraler (Zurich, CH)
Thumbnail

Glycated haemoglobin and the association with long-term survival among patients evaluated for stable angina - a prospective Norwegian cohort

Speaker: Doctor G. Svingen (Bergen, NO)
Thumbnail

Cardioprotective effect of empagliflozin in acute myocardial infarction: the role of ketone bodies availability.

Speaker: Professor J. Badimon (New York, US)
Thumbnail

Impact of chronic GLP-1 receptor agonist and SGLT-2 inhibitor therapy on in-hospital outcomes of patients with diabetes mellitus hospitalized with acute myocardial infarction.

Speaker: Doctor F. Trombara (Milano, IT)
Thumbnail

6 speakers from this session

Professor Philippe Gabriel Steg

Hopital Bichat, Paris (France)
47 presentations
8 followers

Doctor Efthymios Ziogos

The Johns Hopkins University School of Medicine, Baltimore (United States of America)
0 follower

Doctor Simon Kraler

University of Zurich, Zurich (Switzerland)
0 follower

Doctor Gard Frodahl Tveitevaag Svingen

Haukeland University Hospital, Bergen (Norway)
0 follower

Professor Juan Jose Badimon

Icahn School of Medicine at Mount Sinai, New York (United States of America)
0 follower

Doctor Filippo Trombara

Centro Cardiologico Monzino IRCCS, Milano (Italy)
0 follower

This platform is supported by

logo Novo Nordisk